|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.31 USD | +3.42% |
|
+2.58% | +31.00% |
| 27/05 | Argus Raises Viatris Price Target to $18 From $15 | MT |
| 19/05 | Barclays Adjusts Price Target on Viatris to $22 From $17, Maintains Overweight Rating | MT |
Group Viatris Inc.: Relations chart
Listed companies belonging to the same Group: Viatris Inc.
| Company | Market Cap | Manager |
|---|---|---|
| MYLAN LABORATORIES LTD | 0 | B. Hari Babu |
Private companies belonging to the same group as VIATRIS INC.
| Company | Manager |
|---|---|
Mylan Luxembourg SARL | - |
Utah Acquisition Sub, Inc.
 Utah Acquisition Sub, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | - |
Mylan Pharmaceuticals Pvt Ltd.
 Mylan Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | - |
Mylan Pharmaceuticals, Inc.
 Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic prescription products | Heather Bresch |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition